<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-040882</identifier>
<setSpec>0014-2565</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Use of rifabutin in cases of toxicity to rifampicin</dc:title>
<dc:description xml:lang="en">Rifampicin is an essential drug in the present treatment of tuberculosis. On some occasions, it cannot be used due to severe adverse effects. Rifabutin is a drug of the same family, with a similar activity and difference adverse effects. This study describes the beneficial results of the substitution of rifampicin with rifabutin in patients with severe toxicity</dc:description>
<dc:creator>Noguerado Asensio, A</dc:creator>
<dc:creator>Moreno González, B</dc:creator>
<dc:creator>Rodríguez Barrientos, R</dc:creator>
<dc:creator>Rodríguez Blanco, A</dc:creator>
<dc:creator>Vidal Pérez, J. L</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">La rifampicina es un fármaco esencial en el tratamiento actual de la tuberculosis. En algunas ocasiones no se puede utilizar por efectos adversos graves. La rifabutina es un fármaco de la misma familia, con una actividad similar y efectos adversos diferentes. En este estudio se describen los resultados beneficiosos de la sustitución de rifampicina por rifabutina en pacientes con toxicidad intensa</dc:description>
<dc:source>Rev Clin Esp;205(9): 430-432, sep. 2005. tab</dc:source>
<dc:identifier>ibc-040882</dc:identifier>
<dc:title xml:lang="es">Uso de rifabutina en casos de toxicidad a rifampicina</dc:title>
<dc:subject>^d24718^s22012</dc:subject>
<dc:subject>^d331</dc:subject>
<dc:subject>^d31068^s22079</dc:subject>
<dc:subject>^d28611</dc:subject>
<dc:subject>^d12705^s22020</dc:subject>
<dc:subject>^d14798^s22057</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d9362^s22021</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:type>article</dc:type>
<dc:date>200509</dc:date>
</metadata>
</record>
</ibecs-document>
